No article text was recorded for this version.
epigenetic reactivation
Version 1 of 117 papers19 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Remodeling tumor microenvironment with natural products to overcome drug resistance
- Blog: KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability
- Blog: SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition
- Blog: Integrative multi-omics and Mendelian randomization identify WWOX and THBS2 as potential therapeutic targets in mature T/NK-cell lymphoma
- Blog: Azacitidine, Venetoclax Combined with Chidamide (ABC-14 Regimen) As an Induction Therapy for Newly Diagnosed AML: A Real-World Retrospective Analysis By the ABC-14 Collaboration Group
- Blog: Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer
- Blog: Somatostatin Receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer
- Blog: [EFEMP1 suppresses growth and invasion of lung cancer cells by downregulating matrix metalloproteinase-7 expression].
- Blog: The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma
- Blog: Naphthazarin enhances ionizing radiation-induced cell cycle arrest and apoptosis in human breast cancer cells
- Blog: Aberrant expression of RSK4 in breast cancer and its role in the regulation of tumorigenicity
- Blog: Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer
- Blog: Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in�vitro and in�vivo
- Blog: Identification of novel methylated targets in colorectal cancer by microarray analysis and construction of co-expression network
- Blog: A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance
- Blog: Entry of ZSWIM4 to the nucleus is crucial for its inhibition of KIT and BMAL1 in gastrointestinal stromal tumors
- Blog: Correction: OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
History & citation
Current · Permanent link
- This direction split from epigenetic gene silencing (94% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_epigenetic_reactivation_2b86486f,
title = {epigenetic reactivation},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/epigenetic-reactivation/rdr_2b86486fdbeb4bc4b99e78b7cc6f530b},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_epigenetic_reactivation_2b86486f_v1,
title = {epigenetic reactivation},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/epigenetic-reactivation/rdr_2b86486fdbeb4bc4b99e78b7cc6f530b/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}